Public Health Emergency Declared: Understanding the Ebola Outbreak in DRC and Uganda

As of May 26, 2026, the World Health Organization (WHO) has officially determined that the current Ebola disease outbreak caused by the Bundibugyo virus in the Democratic Republic of the Congo (DRC) and Uganda constitutes a Public Health Emergency of International Concern (PHEIC). This designation follows reports of international spread, including confirmed cases in Kampala, Uganda, as of mid-May 2026.

For those following this developing situation, it is essential to understand the nature of the virus, the current response, and how health authorities are working to contain the spread.

What is the Bundibugyo Virus?

Ebola disease is caused by infection with an orthoebolavirus. While there are several types of these viruses, the current outbreak involves the Bundibugyo virus (species Orthoebolavirus bundibugyoense). These viruses are primarily found in sub-Saharan Africa and can cause serious, often deadly illness in humans.

Symptoms typically begin 8 to 10 days after exposure, though the incubation period can range from 2 to 21 days. Early “dry” symptoms often include:

• Fever
• Aches and pains
• Fatigue
• Sore throat and headaches

As the disease progresses, individuals may experience vomiting, diarrhea, rash, and hepatic or renal dysfunction. In severe cases, patients may develop internal and external bleeding.

The Scope of the Current Outbreak

The WHO’s decision to declare a PHEIC was based on scientific evidence, the risk to human health, and the potential for further international spread. As of May 16, 2026, authorities in the DRC reported eight laboratory-confirmed cases and hundreds of suspected cases and deaths across multiple health zones in Ituri Province, including Bunia, Rwampara, and Mongbwalu.

The leadership of both the DRC and Uganda is working in coordination with global health organizations to implement necessary infection control, screening, and emergency service protocols. While the situation is serious, the WHO has noted that it does not currently meet the criteria for a “pandemic emergency” as defined by the International Health Regulations.

Key Takeaways for Public Awareness

• Transmission: Ebola spreads through direct contact with the blood or body fluids of an infected person or through contact with contaminated objects.
• Risk Assessment: Public health agencies continue to monitor the risk of international spread. For many regions, including the United States, the current risk is considered low, though travelers from affected areas should remain vigilant.
• Medical Response: Management of the disease relies on supportive care. While there is an FDA-approved vaccine for the prevention of the Ebola virus (species Orthoebolavirus zairense), treatment protocols for other orthoebolaviruses are highly specialized and focused on stabilizing the patient.

Frequently Asked Questions

How is Ebola diagnosed?

Healthcare providers diagnose Ebola by identifying orthoebolaviruses, viral RNA, or specific antibodies in a patient’s blood samples. This is often done in conjunction with ruling out other conditions like malaria, typhoid, or cholera.

Can Ebola be treated?

Treatment primarily consists of supportive care to manage symptoms and complications, such as shock resulting from fluid loss. The prognosis for patients often depends on early diagnosis and the specific viral species involved.

What should travelers do?

Travelers in or near affected regions should follow the guidance of local health authorities and international bodies like the WHO. This includes practicing rigorous hygiene and avoiding contact with individuals showing signs of illness or areas where the virus is known to be circulating.

As this is an evolving situation, it is critical to rely on information from official sources such as the World Health Organization and the Centers for Disease Control and Prevention for the most current guidance on travel, and safety.